Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes

Current Diabetes Reports

Volumn 14, Issue 12, 2014, Pages 1-11

  Bogdani, Marika ^a   Korpos, Eva ^b   Simeonovic, Charmaine J ^c   Parish, Christopher R ^c   Sorokin, Lydia ^b   Wight, Thomas N ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Australian National University   (Australia)

Author keywords

Cathepsins; Diabetes; Extracellular matrix; Heparan sulfate; Heparanase; Hyaladherins; Hyaluronan; Immune regulation; Islet; Islet infiltration; Laminin

Indexed keywords

COLLAGEN TYPE 4; HEPARAN SULFATE; HYALURONIC ACID; LAMININ; PANCRELIPASE; PROTEOHEPARAN SULFATE; PROTEOGLYCAN;

BASEMENT MEMBRANE; CELL ACTIVATION; CELL FUNCTION; CELL INVASION; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVIEW; VASCULARIZATION; VENULE; ANIMAL; DIABETES MELLITUS, TYPE 1; METABOLISM; PATHOLOGY;

ANIMALS; BASEMENT MEMBRANE; DIABETES MELLITUS, TYPE 1; EXTRACELLULAR MATRIX; HUMANS; PANCREAS; PROTEOGLYCANS;

EID: 84910120838     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0552-7     Document Type: Review

References (95)

1. Hynes RO, Yamada KM. Extracellular matrix biology. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2012. Excellent up-to-date coverage of different ECM components.
2. Karamanos N. Extracellular matrix: pathobiology and signaling. Berlin/Boston: Walter de Gruyter; 2012. Outstanding collection of chapters covering information on how different components of ECM impact cellular signaling and cell phenotype.
3. Mecham RP, editor. The extracellular matrix: an overview. Biology of the extracellular matrix. Berlin: Springer-Verlag; 2011.
4. Hay ED. Cell biology of extracellular matrix. New York: Plenum Press; 1991.
5. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol. 2010;10:712–23. doi:10.1038/nri2852.
6. Pugliese A, Yang M, Kusmarteva I, Heiple T, Vendrame F, Wasserfall C, et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes. 2014;15:1–9. doi:10.1111/pedi.12097.
7. Jiang FX, Harrison LC. Extracellular signals and pancreatic beta-cell development: a brief review. Mol Med. 2002;8:763–70.
8. Reinert RB, Cai Q, Hong JY, Plank JL, Aamodt K, Prasad N, et al. Vascular endothelial growth factor coordinates islet innervation via vascular scaffolding. Development. 2014;141:1480–91. doi:10.1242/dev.098657. This study shows the interconnection between the vascular and neuronal system in pancreatic islet development.
9. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, et al. The vascular basement membrane: a niche for insulin gene expression and beta cell proliferation. Dev Cell. 2006;10:397–405. doi:10.1016/j.devcel.2006.01.015. This study shows how laminins can impact on islet development and insulin production, an area with enormous potential for improved islet transfer.
10. Virtanen I, Banerjee M, Palgi J, Korsgren O, Lukinius A, Thornell LE, et al. Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia. 2008;51:1181–91. doi:10.1007/s00125-008-0997-9.
11. Otonkoski T, Banerjee M, Korsgren O, Thornell LE, Virtanen I. Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab. 2008;10 Suppl 4:119–27. doi:10.1111/j.1463-1326.2008.00955.x.
12. Pavin EJ, Pinto GA, Zollner RL, Vassallo J. Immunohistochemical study of the pancreatic basement membrane in non obese diabetic mice (NOD) with spontaneous autoimmune insulitis. J Submicrosc Cytol Pathol. 2003;35:25–7.
13. Irving-Rodgers HF, Ziolkowski AF, Parish CR, Sado Y, Ninomiya Y, Simeonovic CJ, et al. Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia. 2008;51:1680–8. doi:10.1007/s00125-008-1085-x.
14. Ziolkowski AF, Popp SK, Freeman C, Parish CR, Simeonovic CJ. Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes. J Clin Invest. 2012;122:132–41. doi:10.1172/JCI46177. Hallmark study identifies heparan sulfate (HS) to be critical for islet beta cell survival and HS-degrading heparanase as a novel mechanism of beta cell death in T1D.
15. Korpos E, Kadri N, Kappelhoff R, Wegner J, Overall CM, Weber E, et al. The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes. 2013;62:531–42. doi:10.2337/db12-0432. This work shows that the peri-islet basement membrane is a barrier in front of pancreatic islet infiltrating leukocyte not only in NOD mice but also in human type 1 diabetic pancreases.
16. Tanzer ML. Current concepts of extracellular matrix. J Orthop Sci. 2006;11:326–31. doi:10.1007/s00776-006-1012-2.
17. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326:1216–9. doi:10.1126/science.1176009. An excellent overview of what the ECM is and how it can impact cellular behavior.
18. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195–200. doi:10.1242/jcs.023820.
19. Robert L, Robert AM, Renard G. Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging Pathol Biol (Paris). 2010;58:187–98. doi:10.1016/j.patbio.2009.09.010.
20. Bogdani M, Johnson PY, Potter-Perigo S, Nagy N, Day AJ, Bollyky PL, et al. Hyaluronan and hyaluronan binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes. 2014;63:2727–43. doi:10.2337/db13-1658. A thorough investigation of the involvement of hyaluronan and associated molecules in the pathogenesis of T1D.
21. Behrens DT, Villone D, Koch M, Brunner G, Sorokin L, Robenek H, et al. The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem. 2012;287:18700–9. doi:10.1074/jbc.M111.336073.
22. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 1991;10:3137–46.
23. Mayer U, Kohfeldt E, Timpl R. Structural and genetic analysis of laminin-nidogen interaction. Ann NY Acad Sci. 1998;857:130–42.
24. Mayer U, Mann K, Timpl R, Murphy G. Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur J Biochem. 1993;217:877–84.
25. Aumailley M, Battaglia C, Mayer U, Reinhardt D, Nischt R, Timpl R, et al. Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int. 1993;43:7–12.
26. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development. 2004;131:1619–28. doi:10.1242/dev.01037.
27. Durbeej M. Laminins Cell Tissue Res. 2010;339:259–68. doi:10.1007/s00441-009-0838-2.
28. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol. 2006;6:633–43.
29. Jiang FX, Naselli G, Harrison LC. Distinct distribution of laminin and its integrin receptors in the pancreas. J Histochem Cytochem. 2002;50:1625–32.
30. Banerjee M, Virtanen I, Palgi J, Korsgren O, Otonkoski T. Proliferation and plasticity of human beta cells on physiologically occurring laminin isoforms. Mol Cell Endocrinol. 2012;355:78–86. doi:10.1016/j.mce.2012.01.020.
31. Van Deijnen JH, Van Suylichem PT, Wolters GH, Van Schilfgaarde R. Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res. 1994;277:115–21.
32. Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev. 2003;83:309–36. doi:10.1152/physrev.00023.2002.
33. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678–89. doi:10.1038/nri2156.
34. Brunicardi FC, Stagner J, Bonner-Weir S, Wayland H, Kleinman R, Livingston E, et al. Microcirculation of the islets of Langerhans. Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes. 1996;45:385–92.
35. Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood–brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol. 2001;153:933–46.
36. Wang S, Voisin MB, Larbi KY, Dangerfield J, Scheiermann C, Tran M, et al. Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med. 2006;203:1519–32.
37. Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med. 2009;15:519–27. doi:10.1038/nm.1957.
38. Kenne E, Soehnlein O, Genove G, Rotzius P, Eriksson EE, Lindbom L. Immune cell recruitment to inflammatory loci is impaired in mice deficient in basement membrane protein laminin alpha4. J Leukoc Biol. 2010;88:523–8. doi:10.1189/jlb.0110043.
39. Kappelhoff R, Overall C. The CLIP-CHIP oligonucleotide microarray: dedicated array for analysis of all protease, nonproteolytic homolog, and inhibitor gene transcripts in human and mouse. Curr Protoc Protein Sci 2007. p. Unit 21 19.
40. Gocheva V, Wang HW, Gadea BB, Shree T, Hunter KE, Garfall AL, et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010;24:241–55. doi:10.1101/gad.1874010.
41. Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, et al. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem. 2006;281:6020–9. doi:10.1074/jbc.M509134200.
42. Abdul-Hussien H, Soekhoe RG, Weber E, von der Thusen JH, Kleemann R, Mulder A, et al. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol. 2007;170:809–17. doi:10.2353/ajpath.2007.060522.
43. Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, et al. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res. 2009;69:4537–44. doi:10.1158/0008-5472.
44. Morrison CJ, Butler GS, Rodriguez D, Overall CM. Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol. 2009;21:645–53. doi:10.1016/j.ceb.2009.06.006.
45. Dufour A, Overall CM. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci. 2013;34:233–42. doi:10.1016/j.tips.2013.02.004. This review summarizes the novel substrates of matrix metalloproteinases in inflammation and cancer.
46. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med. 2006;12:317–23. doi:10.1038/nm1361.
47. Ricard-Blum S, Salza R. Matricryptins and matrikines: biologically active fragments of the extracellular matrix. Exp Dermatol. 2014. doi:10.1111/exd.12435.
48. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999;68:729–77. doi:10.1146/annurev.biochem.68.1.729.
49. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 2002;71:435–71. doi:10.1146/annurev.biochem.71.110601.135458.
50. Lindahl U, Kjellen L. Pathophysiology of heparan sulphate: many diseases, few drugs. J Intern Med. 2013;273:555–71. doi:10.1111/joim.12061.
51. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 2011;3. doi:10.1101/cshperspect.a004952.
52. Kreuger J, Kjellen L. Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem. 2012;60:898–907. doi:10.1369/0022155412464972.
53. Casu B, Naggi A, Torri G. Heparin-derived heparan sulfate mimics that modulate inflammation and cancer. Matrix Biol 2010;29:442–52. doi:10.1016/j.matbio.2010.04.003.
54. Hohenester E, Yurchenco PD. Laminins in basement membrane assembly. Cell Adh Migr. 2013;7:56–63. doi:10.4161/cam.21831.
55. Dilts SM, Lafferty KJ. Autoimmune diabetes: the involvement of benign and malignant autoimmunity. J Autoimmun. 1999;12:229–32. doi:10.1006/jaut.1999.0284.
56. Solomon M, Sarvetnick N. The pathogenesis of diabetes in the NOD mouse. Adv Immunol. 2004;84:239–64. doi:10.1016/S0065-2776(04)84007-0.
57. Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, Browder IW, Williams DL. Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med. 2001;30:393–402. doi:10.1016/S0891-5849(00)00485-8.
58. Takahashi I, Noguchi N, Nata K, Yamada S, Kaneiwa T, Mizumoto S, et al. Important role of heparan sulfate in postnatal islet growth and insulin secretion. Biochem Biophys Res Commun. 2009;383:113–8. doi:10.1016/j.bbrc.2009.03.140.
59. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001;108:341–7. doi:10.1172/JCI13662.
60. Couzin-Frankel J. Clinical studies. Trying to reset the clock on type 1 diabetes. Science. 2011;333:819–21. doi:10.1126/science.333.6044.819.
61. DeWeerdt S. Immunomodulators: cell savers. Nature. 2012;485:S4–5.
62. Weissmann B, Meyer K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc. 1954;76:1753–7.
63. Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: an overview. Immunol Cell Biol. 1996;74:A1–7. doi:10.1038/icb.1996.32.
64. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4:528–39.
65. Volpi N, Schiller J, Stern R, Soltes L. Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem. 2009;16:1718–45.
66. Day AJ, Prestwich GD. Hyaluronan-binding proteins: tying up the giant. J Biol Chem. 2002;277:4585–8.
67. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91:221–64. doi:10.1152/physrev.00052.2009.
68. Csoka AB, Stern R. Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology. 2013;23:398–411. doi:10.1093/glycob/cws218. Outstanding review of functional aspects of hyaluronan biology—thought provoking.
69. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature. 2013;499:346–9. doi:10.1038/nature12234.
70. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85:699–715.
71. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27–33.
72. Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol. 2005;26:637–43.
73. Bollyky PL, Bogdani M, Bollyky JB, Hull RL, Wight TN. The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep. 2012;12:471–80. doi:10.1007/s11892-012-0297-0. An excellent review of how hyaluronan regulates innate and adaptive immunity.
74. de la Motte CA. Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;301:G945–9. doi:10.1152/ajpgi.00063.2011.
75. Lesley J, Gal I, Mahoney DJ, Cordell MR, Rugg MS, Hyman R, et al. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem. 2004;279:25745–54.
76. Potter-Perigo S, Johnson PY, Evanko SP, Chan CK, Braun KR, Wilkinson TS, et al. Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol. 2010;43:109–20. doi:10.1165/rcmb.2009-0081OC.
77. Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol. 2012;31:90–100. doi:10.1016/j.matbio.2011.10.004. A nice demonstration of how these components affect T-cell phenotype.
78. Baranova NS, Foulcer SJ, Briggs DC, Tilakaratna V, Enghild JJ, Milner CM, et al. Inter-α-inhibitor impairs TSG-6 induced hyaluronan cross-linking. J Biol Chem. 2013;288:29642–53. doi:10.1074/jbc.M113.477422. Insightful study demonstrating key molecules in the generation of high molecular complexes of hyaluronan.
79. Wang A, de la Motte C, Lauer M, Hascall V. Hyaluronan matrices in pathobiological processes. FEBS J. 2011;278:1412–8. doi:10.1111/j.1742-4658.2011.08069.x.
80. Baranova NS, Nileback E, Haller FM, Briggs DC, Svedhem S, Day AJ, et al. The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. J Biol Chem. 2011;286:25675–86. doi:10.1074/jbc.M111.247395.
81. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106:818–39. doi:10.1021/cr050247k.
82. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, et al. Resolution of lung inflammation by CD44. Science. 2002;296:155–8.
83. Powell JD, Horton MR. Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res. 2005;31:207–18.
84. Atkinson MA, Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes. 2009;16:279–85. doi:10.1097/MED.0b013e32832e06ba.
85. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5:219–26. doi:10.1038/nrendo.2009.21.
86. Galandrini R, Galluzzo E, Albi N, Grossi CE, Velardi A. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol. 1994;153:21–31.
87. Mummert ME, Mohamadzadeh M, Mummert DI, Mizumoto N, Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med. 2000;192:769–79.
88. Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol. 2002;169:4322–31.
89. Mummert ME. Immunologic roles of hyaluronan. Immunol Res. 2005;31:189–206.
90. Bollyky P, Evanko S, Wu R, Potter-Perigo S, Long S, Kinsella B, et al. TH1 cytokines promote hyaluronan production by antigen presenting cells and accumulation at the immune synapse. Cell Mol Immunol. 2010;7:211–20. doi:10.1038/cmi.2010.9.
91. Weiss L, Slavin S, Reich S, Cohen P, Shuster S, Stern R, et al. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci U S A. 2000;97:285–90.
92. Kota DJ, Wiggins LL, Yoon N, Lee RH. TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes. 2013;62:2048–58. doi:10.2337/db12-0931. Interesting study implicating a hyaluronan binding protein as a possible therapeutic target to treat T1D.
93. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155:173–81. doi:10.1111/j.1365-2249.2008.03860.x.
94. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012;209:51–60. doi:10.1084/jem.20111187.
95. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 2006;25:989–1001. doi:10.1016/j.immuni.2006.10.011.